Overview

Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis

Status:
Completed
Trial end date:
2017-02-06
Target enrollment:
Participant gender:
Summary
Participation in the study will last for 3months, with a 1 month screening phase.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Celgene Corporation